Cargando…

Improvement of renal function after human umbilical cord mesenchymal stem cell treatment on chronic renal failure and thoracic spinal cord entrapment: a case report

BACKGROUND: Chronic renal failure is an important clinical problem with significant socioeconomic impact worldwide. Thoracic spinal cord entrapment induced by a metabolic yield deposit in patients with renal failure results in intrusion of nervous tissue and consequently loss of motor and sensory fu...

Descripción completa

Detalles Bibliográficos
Autores principales: Rahyussalim, Ahmad Jabir, Saleh, Ifran, Kurniawati, Tri, Lutfi, Andi Praja Wira Yudha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5707902/
https://www.ncbi.nlm.nih.gov/pubmed/29187247
http://dx.doi.org/10.1186/s13256-017-1489-7
_version_ 1783282538548035584
author Rahyussalim, Ahmad Jabir
Saleh, Ifran
Kurniawati, Tri
Lutfi, Andi Praja Wira Yudha
author_facet Rahyussalim, Ahmad Jabir
Saleh, Ifran
Kurniawati, Tri
Lutfi, Andi Praja Wira Yudha
author_sort Rahyussalim, Ahmad Jabir
collection PubMed
description BACKGROUND: Chronic renal failure is an important clinical problem with significant socioeconomic impact worldwide. Thoracic spinal cord entrapment induced by a metabolic yield deposit in patients with renal failure results in intrusion of nervous tissue and consequently loss of motor and sensory function. Human umbilical cord mesenchymal stem cells are immune naïve and they are able to differentiate into other phenotypes, including the neural lineage. Over the past decade, advances in the field of regenerative medicine allowed development of cell therapies suitable for kidney repair. Mesenchymal stem cell studies in animal models of chronic renal failure have uncovered a unique potential of these cells for improving function and regenerating the damaged kidney. CASE PRESENTATION: We report a case of a 62-year-old ethnic Indonesian woman previously diagnosed as having thoracic spinal cord entrapment with paraplegic condition and chronic renal failure on hemodialysis. She had diabetes mellitus that affected her kidneys and had chronic renal failure for 2 years, with creatinine level of 11 mg/dl, and no urinating since then. She was treated with human umbilical cord mesenchymal stem cell implantation protocol. This protocol consists of implantation of 16 million human umbilical cord mesenchymal stem cells intrathecally and 16 million human umbilical cord mesenchymal stem cells intravenously. Three weeks after first intrathecal and intravenous implantation she could move her toes and her kidney improved. Her creatinine level decreased to 9 mg/dl. Now after 8 months she can raise her legs and her creatinine level is 2 mg/dl with normal urinating. CONCLUSIONS: Human umbilical cord mesenchymal stem cell implantations led to significant improvement for spinal cord entrapment and kidney failure. The major histocompatibility in allogeneic implantation is an important issue to be addressed in the future.
format Online
Article
Text
id pubmed-5707902
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-57079022017-12-06 Improvement of renal function after human umbilical cord mesenchymal stem cell treatment on chronic renal failure and thoracic spinal cord entrapment: a case report Rahyussalim, Ahmad Jabir Saleh, Ifran Kurniawati, Tri Lutfi, Andi Praja Wira Yudha J Med Case Rep Case Report BACKGROUND: Chronic renal failure is an important clinical problem with significant socioeconomic impact worldwide. Thoracic spinal cord entrapment induced by a metabolic yield deposit in patients with renal failure results in intrusion of nervous tissue and consequently loss of motor and sensory function. Human umbilical cord mesenchymal stem cells are immune naïve and they are able to differentiate into other phenotypes, including the neural lineage. Over the past decade, advances in the field of regenerative medicine allowed development of cell therapies suitable for kidney repair. Mesenchymal stem cell studies in animal models of chronic renal failure have uncovered a unique potential of these cells for improving function and regenerating the damaged kidney. CASE PRESENTATION: We report a case of a 62-year-old ethnic Indonesian woman previously diagnosed as having thoracic spinal cord entrapment with paraplegic condition and chronic renal failure on hemodialysis. She had diabetes mellitus that affected her kidneys and had chronic renal failure for 2 years, with creatinine level of 11 mg/dl, and no urinating since then. She was treated with human umbilical cord mesenchymal stem cell implantation protocol. This protocol consists of implantation of 16 million human umbilical cord mesenchymal stem cells intrathecally and 16 million human umbilical cord mesenchymal stem cells intravenously. Three weeks after first intrathecal and intravenous implantation she could move her toes and her kidney improved. Her creatinine level decreased to 9 mg/dl. Now after 8 months she can raise her legs and her creatinine level is 2 mg/dl with normal urinating. CONCLUSIONS: Human umbilical cord mesenchymal stem cell implantations led to significant improvement for spinal cord entrapment and kidney failure. The major histocompatibility in allogeneic implantation is an important issue to be addressed in the future. BioMed Central 2017-11-30 /pmc/articles/PMC5707902/ /pubmed/29187247 http://dx.doi.org/10.1186/s13256-017-1489-7 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Case Report
Rahyussalim, Ahmad Jabir
Saleh, Ifran
Kurniawati, Tri
Lutfi, Andi Praja Wira Yudha
Improvement of renal function after human umbilical cord mesenchymal stem cell treatment on chronic renal failure and thoracic spinal cord entrapment: a case report
title Improvement of renal function after human umbilical cord mesenchymal stem cell treatment on chronic renal failure and thoracic spinal cord entrapment: a case report
title_full Improvement of renal function after human umbilical cord mesenchymal stem cell treatment on chronic renal failure and thoracic spinal cord entrapment: a case report
title_fullStr Improvement of renal function after human umbilical cord mesenchymal stem cell treatment on chronic renal failure and thoracic spinal cord entrapment: a case report
title_full_unstemmed Improvement of renal function after human umbilical cord mesenchymal stem cell treatment on chronic renal failure and thoracic spinal cord entrapment: a case report
title_short Improvement of renal function after human umbilical cord mesenchymal stem cell treatment on chronic renal failure and thoracic spinal cord entrapment: a case report
title_sort improvement of renal function after human umbilical cord mesenchymal stem cell treatment on chronic renal failure and thoracic spinal cord entrapment: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5707902/
https://www.ncbi.nlm.nih.gov/pubmed/29187247
http://dx.doi.org/10.1186/s13256-017-1489-7
work_keys_str_mv AT rahyussalimahmadjabir improvementofrenalfunctionafterhumanumbilicalcordmesenchymalstemcelltreatmentonchronicrenalfailureandthoracicspinalcordentrapmentacasereport
AT salehifran improvementofrenalfunctionafterhumanumbilicalcordmesenchymalstemcelltreatmentonchronicrenalfailureandthoracicspinalcordentrapmentacasereport
AT kurniawatitri improvementofrenalfunctionafterhumanumbilicalcordmesenchymalstemcelltreatmentonchronicrenalfailureandthoracicspinalcordentrapmentacasereport
AT lutfiandiprajawirayudha improvementofrenalfunctionafterhumanumbilicalcordmesenchymalstemcelltreatmentonchronicrenalfailureandthoracicspinalcordentrapmentacasereport